Evaluation of calcium gluconate on reduction of abdominal pain caused by lead toxicity
Phase 3
- Conditions
- ead toxicity in opium addicted patients.
- Registration Number
- IRCT20171009036661N2
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
People over 18 years old
Oral users of opioids with a lead level greater than 20
Exclusion Criteria
1. Mental retardation
Neuropathic diseases such as diabetes
Chronic pain syndromes
High blood pressure and heart disease
Contraindications for calcium gluconate injection, including sensitivity to this group of drugs. Kidney stones. Hypercalcemia. Hypophosphatemia.
pregnant patient
Patient with Asthma
Patients suspected of obstructive bowel obstruction or with acute abdominal symptoms
Other diagnosis other than lead poisoning
Use of psychiatric drugs
Chronic severe
History of Morphine Sensitivity
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ead colic. Timepoint: 15 minutes, 30 minutes and an hour later. Method of measurement: Visual Analogue Scale.
- Secondary Outcome Measures
Name Time Method